Filing Flows › Oscar Health (OSCR) › Q3 2026 › vs Q3 2025
Oscar Health (OSCR) Q3 2026 vs Q3 2025 (year over year)
Oscar Health's revenue rose $2.2B (+72%) from $3.0B in Q3 2025 to $5.1B in Q3 2026. Operating margin 3.5% against -4.3% (+7.8 pts).
Oscar Health, Q3 2026: revenue $5.1B (+72% year over year), operating margin 3.5%, net earnings $167M, operating cash flow −$1.2B. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Operating margin | 3.5% | -4.3% | +7.8 pts |
| Net margin | 3.3% | -4.6% | +7.9 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $5.1B | $3.0B | $2.2B | +72% |
| Operating profit | $178M | −$129M | $307M | — |
| Costs & expenses | $5.0B | $3.1B | $1.8B | +59% |
| Pre-tax earnings | $175M | −$139M | $315M | — |
| SG&A | $722M | $522M | $200M | +38% |
| Other operating costs | $4.2B | $2.6B | $1.6B | +63% |
| Net earnings | $167M | −$137M | $305M | — |
| Income tax | $8.1M | −$1.8M | $9.9M | — |
| Operating cash sources | $1.4B | $855M | $542M | +63% |
| Depreciation & amortization | $6.5M | $7.3M | −$769K | -11% |
| Share-based compensation | $22.3M | $20.5M | $1.8M | +9% |
| Cash used in operations | $1.2B | $965M | $236M | +24% |
| Working capital & other | $1.4B | $855M | $542M | +63% |
Questions
How much did Oscar Health's revenue grow year over year in Q3 2026?
Oscar Health's revenue rose $2.2B (+72%) from $3.0B in Q3 2025 to $5.1B in Q3 2026. Operating margin 3.5% against -4.3% (+7.8 pts).